Pharmacology

Action Mechanism of Action Reference
AGONIST Glucagon receptor agonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Diabetes Mellitus 3 D003920 ClinicalTrials
Hypoglycemia 2 D007003 ClinicalTrials
Diabetes Mellitus, Type 2 1 D003924 ClinicalTrials

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Vascular disorders
13.88
Nervous system disorders
9.77
Cardiac disorders
9.35
General disorders and administration site conditions
8.22
Gastrointestinal disorders
8.07
Respiratory, thoracic and mediastinal disorders
7.65
Infections and infestations
5.67
Metabolism and nutrition disorders
5.52
Renal and urinary disorders
3.97
Blood and lymphatic system disorders
3.54
Injury, poisoning and procedural complications
3.4
Musculoskeletal and connective tissue disorders
3.26
Investigations
2.97
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
2.83

Cross References

Resources Reference
ChEMBL CHEMBL1201618
FDA SRS 1H87NVF4DB